Pediatric Pathologic Fractures
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Pathologic Fracture Does Not Influence Prognosis in Stage IIB Osteosarcoma: a Case–Control Study Dongqing Zuo†, Longpo Zheng†, Wei Sun, Yingqi Hua* and Zhengdong Cai*
Zuo et al. World Journal of Surgical Oncology 2013, 11:148 http://www.wjso.com/content/11/1/148 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case–control study Dongqing Zuo†, Longpo Zheng†, Wei Sun, Yingqi Hua* and Zhengdong Cai* Abstract Objective: This study tested the implication of pathologic fractures on the prognosis in stage IIb osteosarcoma. Methods: A single center retrospective evaluation of clinical management and oncologic outcome was conducted with 15 pathological fracture patients (M:F = 10:5; age: mean 23.2, range 12–42) and 50 non-fracture patients between April 2002 and December 2010. These stage IIB osteosarcoma patients were matched for age, tumor site (femur, tibia, and humerus), and osteosarcoma subtype (i.e., control patients with osteosarcoma in the same sites as the fracture patients). All osteosarcoma patients with pathological fractures underwent brace or cast immobilization, adjuvant chemotherapy, and limb salvage surgery or amputation. Musculoskeletal Tumor Society (MSTS) functional scores were assessed. The mean follow-up time was 34.7 months (range, 8–47 months). Results: Following limb salvage surgery, no statistical differences were observed in major complications (fracture = 20.0%, control = 12.0%, P = 0.43) or local recurrence complications (fracture = 26.7%, control = 14.0%, P = 0.25). Overall 3-year survival rates of the fracture and control groups (66.7% and 75.3%, respectively) were not statistically different (P = 0.5190). Three-year disease-free survival rates of the fracture and control groups were 53.3% and 66.5%, respectively (P = 0.25). -
Evaluating and Treating the Reproductive System
18_Reproductive.qxd 8/23/2005 11:44 AM Page 519 CHAPTER 18 Evaluating and Treating the Reproductive System HEATHER L. BOWLES, DVM, D ipl ABVP-A vian , Certified in Veterinary Acupuncture (C hi Institute ) Reproductive Embryology, Anatomy and Physiology FORMATION OF THE AVIAN GONADS AND REPRODUCTIVE ANATOMY The avian gonads arise from more than one embryonic source. The medulla or core arises from the meso- nephric ducts. The outer cortex arises from a thickening of peritoneum along the root of the dorsal mesentery within the primitive gonadal ridge. Mesodermal germ cells that arise from yolk-sac endoderm migrate into this gonadal ridge, forming the ovary. The cells are initially distributed equally to both sides. In the hen, these germ cells are then preferentially distributed to the left side, and migrate from the right to the left side as well.58 Some avian species do in fact have 2 ovaries, including the brown kiwi and several raptor species. Sexual differ- entiation begins by day 5 in passerines and domestic fowl and by day 11 in raptor species. Differentiation of the ovary is characterized by development of the cortex, while the medulla develops into the testis.30,58 As the embryo develops, the germ cells undergo three phases of oogenesis. During the first phase, the oogonia actively divide for a defined time period and then stop at the first prophase of the first maturation division. During the second phase, the germ cells grow in size to become primary oocytes. This occurs approximately at the time of hatch in domestic fowl. During the third phase, oocytes complete the first maturation division to 18_Reproductive.qxd 8/23/2005 11:44 AM Page 520 520 Clinical Avian Medicine - Volume II become secondary oocytes. -
Metastatic Osseous Pain Control: Bone Ablation and Cementoplasty
328 Metastatic Osseous Pain Control: Bone Ablation and Cementoplasty Alexis Kelekis, MD, PhD, EBIR, FSIR1 Francois H. Cornelis, MD, PhD2 Sean Tutton, MD, FSIR3 Dimitrios Filippiadis, PhD, MSc, EBIR1 1 Division of Diagnostic and Interventional Radiology, 2nd Department of Address for correspondence Alexis Kelekis, MD, PhD, EBIR, FSIR, Radiology, University General Hospital “ATTIKON,” Athens, Greece Division of Diagnostic and Interventional Radiology, 2nd Department 2 Department of Radiology, Université Pierre et Marie Curie, Sorbonne of Radiology, University General Hospital “ATTIKON,” 1 Rimini street, Université, Tenon Hospital, Paris, France 12462 Athens, Greece (e-mail: [email protected]). 3 Division of Vascular and Interventional Radiology, Department of Radiology and Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin Semin Intervent Radiol 2017;34:328–336 Abstract Nociceptive and/or neuropathic pain can be present in all phases of cancer (early and metastatic) and are not adequately treated in 56 to 82.3% of patients. In these patients, radiotherapy achieves overall pain responses (complete and partial responses com- bined) up to 60 and 61%. On the other hand, nowadays, ablation is included in clinical guidelines for bone metastases and the technique is governed by level I evidence. Depending on the location of the lesion in the peripheral skeleton, either the Mirels Keywords scoring or the Harrington (alternatively the Levy) grading system can be used for ► ablation prophylactic fixation recommendation. As minimally invasive treatment options may ► cementoplasty be considered in patients with poor clinical status or limited life expectancy, the aim of ► pain this review is to detail the techniques proposed so far in the literature and to report the ► bone metastasis results in terms of safety and efficacy of ablation and cementoplasty (with or without ► interventional fixation) for bone metastases. -
Benign Fibro-Osseous Lesions Plus…
“Vision is the art of seeing things invisible.” Jonathan Swift 1667 - 1745 Benign Fibro-osseous Lesions Plus… Steven R. Singer, DDS [email protected] 212.305.5674 Benign Fibro-osseous Lesions Fibrous Dysplasia A group of lesions in which normal bone is Localized change in bone metabolism replaced initially by fibrous connective tissue Normal cancellous bone is replaced by Over time, the lesion is infiltrated by osteoid fibrous connective tissue and cementoid tissue The connective tissue contains varying amounts of abnormal bone with irregular This is a benign and idiopathic process trabeculae Trabeculae are randomly oriented. (Remember that normal trabeculae are aligned to respond to stress) Fibrous Dysplasia Fibrous Dysplasia Lesions may be solitary (monostotic) or Fibrous dysplasia is non-hereditary involve more than one bone (polyostotic) Caused by a mutation in a somatic cell. Monostotic form accounts for 70% of all Extent of lesions depends on the timing of cases the mutation. Polyostotic form is more common in the first If the mutation occurs earlier, the disease decade will be more widespread throughout the M=F except in McCune-Albright syndrome, body. An example is McCune-Albright which is almost exclusively found in females Syndrome 1 Fibrous Dysplasia Fibrous Dysplasia McCune-Albright Syndrome • Monostotic and polyostotic forms usually -Almost exclusively begins in the second decade of life females -Polyostotic fibrous • Slow, painless expansion of the jaws dysplasia • Patients may complain of swelling or have -
Orthopedic-Conditions-Treated.Pdf
Orthopedic and Orthopedic Surgery Conditions Treated Accessory navicular bone Achondroplasia ACL injury Acromioclavicular (AC) joint Acromioclavicular (AC) joint Adamantinoma arthritis sprain Aneurysmal bone cyst Angiosarcoma Ankle arthritis Apophysitis Arthrogryposis Aseptic necrosis Askin tumor Avascular necrosis Benign bone tumor Biceps tear Biceps tendinitis Blount’s disease Bone cancer Bone metastasis Bowlegged deformity Brachial plexus injury Brittle bone disease Broken ankle/broken foot Broken arm Broken collarbone Broken leg Broken wrist/broken hand Bunions Carpal tunnel syndrome Cavovarus foot deformity Cavus foot Cerebral palsy Cervical myelopathy Cervical radiculopathy Charcot-Marie-Tooth disease Chondrosarcoma Chordoma Chronic regional multifocal osteomyelitis Clubfoot Congenital hand deformities Congenital myasthenic syndromes Congenital pseudoarthrosis Contractures Desmoid tumors Discoid meniscus Dislocated elbow Dislocated shoulder Dislocation Dislocation – hip Dislocation – knee Dupuytren's contracture Early-onset scoliosis Ehlers-Danlos syndrome Elbow fracture Elbow impingement Elbow instability Elbow loose body Eosinophilic granuloma Epiphyseal dysplasia Ewing sarcoma Extra finger/toes Failed total hip replacement Failed total knee replacement Femoral nonunion Fibrosarcoma Fibrous dysplasia Fibular hemimelia Flatfeet Foot deformities Foot injuries Ganglion cyst Genu valgum Genu varum Giant cell tumor Golfer's elbow Gorham’s disease Growth plate arrest Growth plate fractures Hammertoe and mallet toe Heel cord contracture -
Briggs Healthcare Company
8/8/2019 Selman-Holman, A Briggs Healthcare Company Lisa Selman-Holman JD, BSN, RN, HCS-D, COS-C AHIMA Approved ICD-10-CM Trainer/Ambassador 214.550.1477 [email protected] www.selmanholman.com 2 Briggs Healthcare Mary Madison, RN, RAC-CT, CDP Clinical Consultant [email protected] www.briggshealthcare.com www.briggshealthcare.blog 3 1 8/8/2019 Common Trap #1: Fractures 4 Fractures—Basic Concepts • Fractures are coded with 7th characters of A, D and various other 7th characters. • The fracture is still coded (not aftercare) when surgeries are performed to repair the fracture, i.e. ORIF and joint replacement. 5 Fractures • Classifications of fractures: • Open or closed • Default is closed • Gustilo grade, if open • Displaced or non-displaced • Default is displaced • Traumatic or pathological • Traumatic: bone breaks due to fall or injury • Pathological: bone breaks due to a disease of the bone, a tumor or infection 6 2 8/8/2019 7th Character Convention • 7th characters are not used in all ICD‐10‐CM chapters – Used in Musculoskeletal, Obstetrics, Injuries, External Causes chapters • Eyes for laterality, Gout for tophi and Coma • Different meaning depending on section where it is being used (Go up to the box) • Must always be used in the 7th character position • When 7th character applies, codes missing 7th character are invalid 7 Application of 7th Characters in Chapter 19 • Most, BUT NOT ALL, categories in chapter 19 have a 7th character requirement for each applicable code. A for • A = Initial encounter Awful or Active • D = Subsequent encounter D is the • S = Sequela Default S is for Sometimes • More choices for 7th characters for fractures 8 Chapter 19 Guideline A vs D • While the patient may be seen by a new or different provider over the course of treatment for an injury, assignment of the 7th character is based on whether the patient is undergoing active treatment and not whether the provider is seeing the patient for the first time. -
Mosaic Klinefelter Syndrome Unveiled by Acute Vertebral Fracture in a Middle-Aged Man
LESSONS OF THE MONTH Clinical Medicine 2021 Vol 21, No 4: e420–2 Lessons of the month 3: Mosaic Klinefelter syndrome unveiled by acute vertebral fracture in a middle-aged man Authors: Aye Chan Maung,A Jenny YC Hsieh,B David CarmodyC and Swee Du SoonC Klinefelter syndrome (KS) is the most common sex Table 1. Initial investigations done for secondary chromosome disorder in males. It is the result of two or more X chromosomes in a phenotypic male. In addition to primary osteoporosis hypogonadism affecting male sexual development, it is Day 2 Day 3 Reference range associated with a series of comorbidities such as osteoporosis, ABSTRACT Renal panel psychiatric and cognitive disorders, metabolic syndromes, Urea, mmol/L 3.8 2.8–7.7 and autoimmune diseases. A broad spectrum of phenotypes Sodium, mmol/L 140 135–145 has been described and many cases remain undiagnosed Potassium, mmol/L 3.7 3.5–5.3 throughout their lifespan. In this case report, we describe a Chloride, mmol/L 100 96–108 case of mosaic KS unmasked by acute vertebral fracture. Bicarbonate, mmol/L 27.7 19–31 Glucose, mmol/L 5.8 3.1–7.8 KEYWORDS: Klinefelter syndrome, primary hypogonadism, Creatinine, μmol/L 64 50–90 osteoporosis, vertebral fracture Electrolytes DOI: 10.7861/clinmed.2021-0348 Calcium, mmol/L 2.24 2.10–2.60 Phosphate, mmol/L 1.12 0.65–1.65 Magnesium, mmol/L 0.91 0.65–0.95 Case presentation Thyroid function test Free T4, pmol/L 10.7 10–20 A 56-year-old man presented to the emergency department TSH, mU/L 2.31 0.4–4.0 with worsening back pain of a 2-week duration despite rest and analgesia prescribed by his family physician. -
The Early Detection of Osteoporosis in a Cohort of Healthcare Workers: Is There Room for a Screening Program?
International Journal of Environmental Research and Public Health Case Report The Early Detection of Osteoporosis in a Cohort of Healthcare Workers: Is There Room for a Screening Program? Carmela Rinaldi 1,2,* , Sara Bortoluzzi 1 , Chiara Airoldi 1 , Fabrizio Leigheb 1,2 , Daniele Nicolini 1, Sophia Russotto 3, Kris Vanhaecht 4 and Massimiliano Panella 1 1 Department of Translational Medicine, University of Eastern Piedmont (UPO), 28100 Novara, Italy; [email protected] (S.B.); [email protected] (C.A.); [email protected] (F.L.); [email protected] (D.N.); [email protected] (M.P.) 2 University Hospital “Maggiore della Carità”, 28100 Novara, Italy 3 School of Medicine, University of Eastern Piedmont (UPO), 28100 Novara, Italy; [email protected] 4 KU Leuven Institute for Healthcare Policy, 3000 Leuven, Belgium; [email protected] * Correspondence: [email protected] Abstract: Workforce aging is becoming a significant public health problem due to the resulting emergence of age-related diseases, such as osteoporosis. The prevention and early detection of osteoporosis is important to avoid bone fractures and their socio-economic burden. The aim of this study is to evaluate the sustainability of a screening workplace program able to detect workers with osteoporosis. The screening process included a questionnaire-based risk assessment of 1050 healthcare workers followed by measurement of the bone mass density (BMD) with a pulse-echo ultrasound (PEUS) at the proximal tibia in the at-risk subjects. Workers with a BMD value ≤ 0.783 g/cm2 were referred to a specialist visit ensuring a diagnosis and the consequent prescriptions. -
Musculoskeletal Radiology
MUSCULOSKELETAL RADIOLOGY Developed by The Education Committee of the American Society of Musculoskeletal Radiology 1997-1998 Charles S. Resnik, M.D. (Co-chair) Arthur A. De Smet, M.D. (Co-chair) Felix S. Chew, M.D., Ed.M. Mary Kathol, M.D. Mark Kransdorf, M.D., Lynne S. Steinbach, M.D. INTRODUCTION The following curriculum guide comprises a list of subjects which are important to a thorough understanding of disorders that affect the musculoskeletal system. It does not include every musculoskeletal condition, yet it is comprehensive enough to fulfill three basic requirements: 1.to provide practicing radiologists with the fundamentals needed to be valuable consultants to orthopedic surgeons, rheumatologists, and other referring physicians, 2.to provide radiology residency program directors with a guide to subjects that should be covered in a four year teaching curriculum, and 3.to serve as a “study guide” for diagnostic radiology residents. To that end, much of the material has been divided into “basic” and “advanced” categories. Basic material includes fundamental information that radiology residents should be able to learn, while advanced material includes information that musculoskeletal radiologists might expect to master. It is acknowledged that this division is somewhat arbitrary. It is the authors’ hope that each user of this guide will gain an appreciation for the information that is needed for the successful practice of musculoskeletal radiology. I. Aspects of Basic Science Related to Bone A. Histogenesis of developing bone 1. Intramembranous ossification 2. Endochondral ossification 3. Remodeling B. Bone anatomy 1. Cellular constituents a. Osteoblasts b. Osteoclasts 2. Non cellular constituents a. -
NCT02338492 Study Protocol January 6, 2016
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus from Metastatic Bone Disease NCT02338492 Study Protocol January 6, 2016 IlluminOss Medical, Inc. – U.S. Pathological Humerus Fractures Confidential Study ID#: 14-03-PATHOLHUM-02 A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus from Metastatic Bone Disease Protocol Number: 14-03-PATHOLHUM-02 Sponsor: IlluminOss Medical, Inc. 993 Waterman Avenue East Providence, RI 02914 USA Version Release date: 6 January 2016 CONFIDENTIAL This investigational protocol contains confidential information for use by the Principal Investigators and their designated representatives participating in this clinical study. It should be held confidential and maintained in a secure location. It should not be copied or made available for review by any unauthorized person or firm. DO NOT COPY Version 5.0 6 January 2016 Page 1 of 60 IlluminOss Medical, Inc. – U.S. Pathological Humerus Fractures Confidential Study ID#: 14-03-PATHOLHUM-02 Investigator Responsibility Prior to participation in this study, the appointed Principal Investigator at the Investigational Site (hereafter referred to as “Principal Investigator” or “PI”) must obtain written approval from his/her Institutional Review Board (IRB). This approval must be in the PI’s name and a copy of the approval letter must be sent to the Sponsor, IlluminOss Medical, Inc. or their representative along with the IRB approved Informed Consent Form and the signed Clinical Study Agreement (CSA), prior to the first clinical use of the investigational device. -
Intramuscular Myxoma Associated with Fibrous Dysplasia
Mazabraud’s Syndrome: Intramuscular Myxoma Associated with Fibrous Dysplasia Authors: Dr Fevziye Kabukcuoglu and Dr Yavuz Kabukcuoglu Creation date: January 2005 Scientific Editor: Prof Loic Guillevin Department of Pathology and Department of Orthopedics and Traumatology. Sisli Etfal Training and Research Hospital, Istanbul Turkey. [email protected] Abstract Key words Definition and disease name Differential Diagnosis Incidence Etiology Clinical Description Radiologic findings Histopathology Treatment Unresolved Questions References Abstract Mazabraud’s syndrome is a rare disease known as the association of intramuscular myxoma with fibrous dysplasia. The number of reported cases in 2004 is 55. Myxomas generally occur as multiple masses and fibrous dysplasia most commonly appear with its polyostotic form. Both lesions tend to involve the same anatomical region. Patients usually present with a painless mass with a history of long duration due top lack of symptoms. Most fibrous dysplasias are asymptomatic while some may appear with pain, skeletal deformities or fractures. Generally fibrous dysplasias occur during the growth period and the myxomas appear during adult life. The relationship between fibrous dysplasia and myxoma remains unclear, where an underlying localized error in tissue metabolism has been proposed. Molecular genetic analysis has shown activating mutations in GNAS1 gene. Several benign lesions as well as richly myxoid malignant lesions may be confused with myxoma. Histopathologic examination should be carried out to exclude malignancy. Treatment is dependent on the extent of the lesions. Malignant transformation of myxoma is not reported, although local recurrence may be expected if incompletely resected. While sarcomatous transformation is uncommon for fibrous dysplasia, greater risk has been reported for Mazabraud’s syndrome. -
Fracture Risk with Pressurized-Spray Cryosurgery
An Original Study Fracture Risk With Pressurized-Spray Cryosurgery R. Jay Lee, MD, Joel L. Mayerson, MD, and Martha Crist, RN extends the margin of tumor cell removal.2 Gage and Abstract colleagues3 and Schreuder and colleagues4 found that Forty-two patients treated with curettage, burring, direct cellular apoptosis is caused by bone necrosis secondary pressurized cryotherapy, and bone grafting or cementa- to formation of ice crystals and membrane disruption tion were retrospectively reviewed. There were no patho- occurring at temperatures below –21°C. logic fractures in this study group, compared with a 17% When cryosurgery was first used, it proved to be an fracture rate in recent studies using the “direct pour” technique. Direct pressurized cryotherapy was used in effective adjuvant in the treatment of bone tumors. 3 separate freezing cycles in each case. This approach In early studies involving liquid nitrogen adjuvant 1,2 may significantly reduce the risk for fracture compared therapy, Marcove reported local recurrence rates of with historical controls using the direct-pour technique. 4% to 10%. Subsequent studies confirmed no adverse increase in recurrence rates over wide resection in benign-aggressive, low-grade primary bone sarcomas, ryosurgery involves use of liquid nitrogen as an and metastatic lesions.4-8 However, cryosurgery is not adjuvant to induce tissue necrosis and destruc- a benign adjuvant in the treatment of bone tumors. As tion of tumor cells. In 1969, Marcove and use of cryosurgery has become prevalent, investigators Miller1 used liquid nitrogen in the surgical have noted several secondary posttreatment complica- Cmanagement of a metastatic carcinoma of the proximal tions: infection, nerve palsy, soft-tissue damage, and humerus, and later for treatment of a variety of benign pathologic fracture.2,6,9-12 and low-grade malignant bone tumors.